Funder
Roy Castle Lung cancer foundation
University of Nottingham John Turland fund
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference195 articles.
1. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†;Früh;Ann. Oncol.,2013
2. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung Cancer;Horn;N. Engl. J. Med.,2018
3. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial;Paz-Ares;Lancet,2019
4. British national formulary- Atezolizumab,2020
5. 30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study;Wallington;Lancet Oncol.,2016